Impact1: Supporting Innovation in Pediatric and Maternal Health-5 Years of Outcomes.

Abstract

Impact1 at the Stanford Mussallem Center for Biodesign was established in 2019 through its core partnership with UCSF as an FDA-funded Pediatric Device Consortium. We hypothesized that providing innovators in pediatric and maternal healthcare with mentorship, connections to experts, and grant funding would promote development, validation, approval, and commercialization of safe and effective health technologies for pediatric and maternal patients, and lead to positive broader impacts, measured a